摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tris(4-methylpentyl)amine

中文名称
——
中文别名
——
英文名称
tris(4-methylpentyl)amine
英文别名
(i-Pr(CH2)2CH2)2NH;triisohexyl-amine;Triisohexyl-amin;4-methyl-N,N-bis(4-methylpentyl)pentan-1-amine
tris(4-methylpentyl)amine化学式
CAS
——
化学式
C18H39N
mdl
——
分子量
269.514
InChiKey
RGBALPIVWBXKOQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.4
  • 重原子数:
    19
  • 可旋转键数:
    12
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    3.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    4-甲基-1-戊醇 在 bis[dichloro(pentamethylcyclopentadienyl)iridium(III)] 、 ammonium acetate 、 碳酸氢钠 作用下, 反应 17.5h, 以55%的产率得到tris(4-methylpentyl)amine
    参考文献:
    名称:
    A New Atom-Economical and Selective Synthesis of Secondary and Tertiary Alkylamines by Means of Cp*Iridium Complex Catalyzed Multiple N-Alkylation of Ammonium Salts with Alcohols without Solvent
    摘要:
    通过使用(五甲基环戊二烯基)铱(Cp*Ir)络合物催化,无需溶剂的情况下,实现了一项针对仲、叔烷基胺的新型原子经济性和选择性合成方法,即对铵盐进行多次N-烷基化反应,原料为伯、仲醇。
    DOI:
    10.1055/s-0028-1087996
点击查看最新优质反应信息

文献信息

  • Selective Synthesis of Secondary and Tertiary Amines by Cp*Iridium-Catalyzed Multialkylation of Ammonium Salts with Alcohols
    作者:Ryohei Yamaguchi、Shoko Kawagoe、Chiho Asai、Ken-ichi Fujita
    DOI:10.1021/ol702522k
    日期:2008.1.1
    synthesis of secondary and tertiary amines has been achieved by means of Cp*Ir-catalyzed multialkylation of ammonium salts with alcohols without solvent: the reactions of ammonium acetate with alcohols gave tertiary amines exclusively, while those of ammonium tetrafluoroborate afforded secondary amines selectively. Using this method, secondary 5- and 6-membered cyclic amines were synthesized from ammonium
    通过Cp * Ir催化的盐与醇的无溶剂多烷基化反应已经实现了仲胺和叔胺的有效选择性合成:乙酸铵与醇的反应仅产生叔胺,而四硼酸的胺选择性地提供了仲胺。使用这种方法,在一锅中由四硼酸和二醇合成了五元​​和六元仲胺。
  • PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE
    申请人:Okamoto Kuniaki
    公开号:US20120130107A1
    公开(公告)日:2012-05-24
    Object To provide a method for producing a bis-quaternary ammonium salt efficiently and a novel synthetic intermediate thereof. Solution The present invention relates to a method for producing a bis-quaternary ammonium salt represented by a general formula [3] which comprises reacting a disulfonic acid ester represented by a general formula [1] (in the formula, definitions of two R 1 's and T are as described in claim 1 ) with a tertiary amine represented by a general formula [2] (in the formula, definitions of R 3 to R 5 are as described in claim 1 ), and a disulfonic acid ester represented by a general formula [1′] (in the formula, two R 16 's represent independently a halogen atom or a C1-C3 fluoroalkyl group, and two m's represent independently an integer of 1 to 5).
    提供一种高效生产双季盐和其新型合成中间体的方法。本发明涉及一种生产由通用式[3]表示的双季盐的方法,包括将由通用式[1]表示的二磺酸(在该式中,两个R1和T的定义如权利要求1中所述)与由通用式[2]表示的三级胺(在该式中,R3到R5的定义如权利要求1中所述)以及由通用式[1']表示的二磺酸(在该式中,两个R16独立表示卤原子或C1-C3氟烷基,两个m独立表示1至5的整数)反应。
  • ABUSE DETERRENT AND ANTI-DOSE DUMPING PHARMACEUTICAL SALTS USEFUL FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER
    申请人:King Clifford Riley
    公开号:US20120028960A1
    公开(公告)日:2012-02-02
    A pharmaceutical composition comprising a drug substance consisting essentially of a pharmaceutically acceptable organic acid addition salt of an amine containing pharmaceutically active compound wherein the amine containing pharmaceutical active compound is selected from the group consisting of racemic or single isomer ritalinic acid or phenethylamine derivatives and the drug substance has a physical form selected from amorphous and polymorphic.
    一种药物组合物,包括基本上由含有药用活性化合物的胺的药用可接受的有机酸加合盐组成的药物物质,其中含有药用活性化合物的胺被选择自光学异构体或单异构体利他林酸或乙胺生物的群体,并且该药物物质具有从无定形到多型的物理形式。
  • PROCESS FOR PRODUCING ESTER COMPOUND
    申请人:Imazeki Shigeaki
    公开号:US20100324314A1
    公开(公告)日:2010-12-23
    PROBLEM To provide an environmentally-friendly method for producing industrially an ester compound. SOLUTION The present invention is a method for producing an ester compound which comprises subjecting a carboxylic acid and an alcohol to dehydration-condensation reaction using an involatile acid catalyst and then removing the residual acid catalyst by bringing a weak basic substance into contact with the residual acid catalyst.
    问题提供一种生产工业化合物的环保方法。 解决方案是一种生产化合物的方法,包括将羧酸和醇经过缩合反应,使用一种不挥发的酸催化剂,然后通过将弱碱性物质与残留的酸催化剂接触来去除残留的酸催化剂
  • IONIC LIQUID CONTAINING ALLYLSULFONATE ANION
    申请人:Watahiki Tsutomu
    公开号:US20120157680A1
    公开(公告)日:2012-06-21
    PROBLEM: Providing a novel ionic liquid, which is low-cost, environment-friendly, and has low viscosity and melting point. MEANS FOR SOLVING THE PROBLEM: The present invention is the invention of the ionic liquid represented by the general formula [1]: wherein, R 1 to R 3 and n pieces of R 4 each independently represent hydrogen atom or alkyl group having 1 to 4 carbon atoms, R 5 to R 7 each independently represent alkyl group, aralkyl group, or aryl group, R 8 represents alkyl group, aralkyl group, aryl group, or the one represented by the general formula [2]: (wherein T represents alkylene chain having 1 to 8 carbon atoms, n represents 1 or 2, and R 1 to R 7 are the same as the above-described), X represents nitrogen atom or phosphorus atom, n represents 1 or 2. When n is 1, R 3 and R 4 are bound and may form cyclohexene ring together with the adjacent carbon atoms. In addition, when X is nitrogen atom, R 5 to R 7 or R 5 to R 6 may form hetero ring with nitrogen atom binding thereto}.
    问题:提供一种新型离子液体,成本低、环保,并具有低粘度和熔点。 解决问题的方法:本发明是一种由通式[1]表示的离子液体的发明:其中,R1到R3和n个R4分别独立表示原子或具有1到4个原子的烷基基团,R5到R7分别独立表示烷基基团、芳基烷基基团或芳基基团,R8表示烷基基团、芳基烷基基团、芳基基团或由通式[2]表示的基团:(其中T表示具有1到8个原子的烷基链,n表示1或2,R1到R7与上述相同),X表示原子或原子,n表示1或2。当n为1时,R3和R4结合并且可能与相邻原子一起形成环己烯环。此外,当X为原子时,R5到R7或R5到R6可能与结合在一起的原子形成杂环}。
查看更多

同类化合物

(乙腈)二氯镍(II) (R)-(-)-α-甲基组胺二氢溴化物 (N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-3-氨基环丁烷甲腈盐酸盐 顺式-2-羟基甲基-1-甲基-1-环己胺 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺二盐酸盐 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷